JP2001522229A - 抗酸化剤タンパク質2、遺伝子及びそれらの使用方法 - Google Patents

抗酸化剤タンパク質2、遺伝子及びそれらの使用方法

Info

Publication number
JP2001522229A
JP2001522229A JP53515698A JP53515698A JP2001522229A JP 2001522229 A JP2001522229 A JP 2001522229A JP 53515698 A JP53515698 A JP 53515698A JP 53515698 A JP53515698 A JP 53515698A JP 2001522229 A JP2001522229 A JP 2001522229A
Authority
JP
Japan
Prior art keywords
aop2
polypeptide
nucleic acid
seq
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP53515698A
Other languages
English (en)
Japanese (ja)
Inventor
ペイジエン,ビバリー
ベイアー,デイビツド・アール
Original Assignee
ザ・ジヤクソン・ラボラトリー
ザ・ブリガム・アンド・ウイメンズ・ホスピタル・インコーポレーテツド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ザ・ジヤクソン・ラボラトリー, ザ・ブリガム・アンド・ウイメンズ・ホスピタル・インコーポレーテツド filed Critical ザ・ジヤクソン・ラボラトリー
Publication of JP2001522229A publication Critical patent/JP2001522229A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP53515698A 1997-04-02 1998-04-01 抗酸化剤タンパク質2、遺伝子及びそれらの使用方法 Pending JP2001522229A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4089797P 1997-04-02 1997-04-02
US60/040,897 1997-04-02
PCT/US1998/006666 WO1998043666A1 (fr) 1997-04-02 1998-04-01 Proteine anti-oxydante 2, gene et procedes d'utilisation correspondants

Publications (1)

Publication Number Publication Date
JP2001522229A true JP2001522229A (ja) 2001-11-13

Family

ID=21913589

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53515698A Pending JP2001522229A (ja) 1997-04-02 1998-04-01 抗酸化剤タンパク質2、遺伝子及びそれらの使用方法

Country Status (4)

Country Link
EP (1) EP1005360A4 (fr)
JP (1) JP2001522229A (fr)
CA (1) CA2285631A1 (fr)
WO (1) WO1998043666A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006505290A (ja) * 2002-11-10 2006-02-16 インスティテュート オブ セル バイオフィジクス ロシアン アカデミー オブ サイエンシーズ 抗酸化医薬化合物、ポリペプチドの産生方法、治療方法

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2798672B1 (fr) * 1999-09-17 2003-10-31 Commissariat Energie Atomique Formes acides des peroxyredoxines et leur utilisation comme moyen de diagnostic
AUPR221300A0 (en) * 2000-12-20 2001-01-25 Malaysian Palm Oil Board A molecular marker
WO2012075911A1 (fr) * 2010-12-06 2012-06-14 Li Jianyuan Utilisation d'une protéine prx-6 humaine recombinante dans le traitement d'une brûlure et d'un ébouillantage et/ou d'une lésion cornéenne

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2093008A1 (fr) * 1990-10-01 1992-04-02 Charles H. Hennekens Utilisation therapeutique de beta-carotene et de vitamine e pour empecher les troubles vasculaires importants

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006505290A (ja) * 2002-11-10 2006-02-16 インスティテュート オブ セル バイオフィジクス ロシアン アカデミー オブ サイエンシーズ 抗酸化医薬化合物、ポリペプチドの産生方法、治療方法

Also Published As

Publication number Publication date
EP1005360A4 (fr) 2001-02-07
EP1005360A1 (fr) 2000-06-07
WO1998043666A1 (fr) 1998-10-08
CA2285631A1 (fr) 1998-10-08

Similar Documents

Publication Publication Date Title
WO1999038965A1 (fr) Gene de la calvitie chez l'homme, proteine et utilisations associees
JP2001511002A (ja) Ts10q23.3と称する腫瘍抑制因子
JP2003501026A (ja) 脂質代謝転写因子
US20040010812A1 (en) Human hyaluronan receptor
JP2001522229A (ja) 抗酸化剤タンパク質2、遺伝子及びそれらの使用方法
JP2001503631A (ja) 緑内障に関連するタンパク質ならびに対応する核酸とそれらの治療および診断への利用
JP2001514015A (ja) Ts10q23.3と称する腫瘍抑制因子
JP2003517812A (ja) PrP様遺伝子
JP2004502444A (ja) 筋選択的カルシニューリン相互作用タンパク質(mcip)に関連する方法および組成物
JP2002500623A (ja) スプルーティタンパク質およびコーディング配列
JP4651893B2 (ja) 新規ポリペプチド、新規dna、新規抗体および新規遺伝子改変動物
CA2314677A1 (fr) Genes associes a l'asthme
US7718787B2 (en) Gene families associated with cancers
JPH10327866A (ja) ヘリカーゼをコードするヒトの遺伝子,cdc28−#3
US20030054446A1 (en) Novel retina-specific human proteins C7orf9, C12orf7, MPP4 and F379
JPH10146188A (ja) ヒトのウェルナー症候群の原因遺伝子に対応するマウス遺伝子及び該遺伝子がコードするタンパク質
US20020142417A1 (en) Antioxidant protein 2, gene and methods of use therefor
JP2001517954A (ja) Noey2遺伝子組成物およびその使用方法
JP2004528822A (ja) 筋特異的筋節カルシニューリン結合タンパク質(カルサルシン)に関する方法および組成物
US20060234286A1 (en) Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses
JPWO2002064770A1 (ja) 新規スカベンジャー受容体クラスa蛋白質
WO2001005803A1 (fr) Nouveaux adnc associes a des nephropathies
US20060121471A1 (en) Gene families associated with stomach cancer
WO2001098456A2 (fr) Identification d'adnc associes a l'hyperplasie prostatique benigne
JP2005506042A (ja) 細胞トランスポーターをコードするポリヌクレオチド、およびその使用方法